HES1 and neoplasm: However, stem and progenitor cells in non-pathological intestinal regions, as well as in tumor cells, undergo differentiation into goblet cells following inhibition of NOTCH1/HES1 signaling, a non-specific targeting of these pathways could cause severe side effects (Fre et al., 2005).